Basel Biomed Symposium 2025
On Friday, May 23, 2025, we will celebrate the laying of the foundation stone of the new building for the Department of Biomedicine at the 51吃瓜. We are using this occasion to launch the Basel Biomed Symposium.
The Basel Biomed Symposium aims to promote scientific networking, cooperation and innovation across the impressive Basel life Science ecosystem. In four sessions, the 1st Basel Biomed Symposium will highlight value chains of biomedical research from basic biology to clinical application.
Program, as of May 8, 2025
Friday, May 23, 2025, Biozentrum, 51吃瓜
Maurice E. Müller Lecture Hall U1.111
8.45: Welcome and Intro (all Organisers)
08.50 – 10.10: Session I: From Cell Biology to Cell and Tissue Engineering and Therapy
Chairs: Ivan Martin / Prisca Liberali
Ivan Martin (Uni Basel, DBM**)
Introducing the Department of Biomedicine
Sai Reddy (D-BSSE, ETHZ*)
Next-generation protein engineering for immunotherapy
Mirjam Christ-Crain (USB*)
Introducing the University Hospital Basel
Nina Khanna / Heinz Läubli (USB*)
Cell therapies: bridging translation into clinical practice
Stefanie Urlinger (Cimeio)
Hematopoietic stem cell engineering enables universal blood cancer therapy
Prisca Liberali (FMI/D-BSSE*)
Cell Coordination in Intestinal Development and Repair
Botond Roska (IOB*)
Introducing the Institute of Molecular and Clinical Ophthalmology Basel
Botond Roska (IOB*)
Cell type targeted mitochondria therapy
Matthias Lütolf (IHB/Roche*)
Introducing the Institute of Human Biology
10.10: Coffee
10.35 – 11.55: Session II: Digital Medicine and AI in Medicine
Chairs: Daniel Müller / Kirsten Taylor
Daniel Müller (ETHZ/D-BSSE*)
Introducing the Department of Biosystems Science and Engineering
Michael Moor (D-BSSE*)
Tool-using medical AI agents
Judith Zaugg (Uni Basel, DBM*)
Systems epigenetics and spatial profiling to study disease mechanisms
Georg Holländer (BRCCH*)
Introducing the Basel Research Center for Child Health
Jens Eckstein (USB*)
Artificial Intelligence in Medicine: Transforming Diagnostics, Treatment, and Patient Care
Philippe Cattin (Uni Basel, DBE*)
Introducing the Department of Biomedical
Philippe Cattin (Uni Basel, DBE*)
Leveraging AI and Diffusion Models for Patient Specific Surgical Plans
Kirsten Taylor (Roche)
Digital biomarkers: Remote monitoring of neurologic signs in clinical drug development of neurodegenerative disorders
Jürg Utzinger (Swiss TPH*)
Introducing the Swiss Tropical and Public Health Institute
12.00: Break «Grundsteinlegung» New DBM and Lunch / Networking
13.30 – 14.50: Session III: From Molecular Pathways to Personalised Medicine and Cancer Therapy
Chairs: Primo Schär / Adrian Britschgi
Markus Lill (Uni Basel, DPS *)
Introducing the Department of Pharmaceutical Sciences
Walter Weber (USB*)
Surgical De-escalation to Improve the Quality of Life of Patients with Breast Cancer
Mohamed Bentires-Alj (Uni Basel, DBM*)
Breast Tumor Heterogeneity and Metastasis – From Mechanisms to Personalised Treatments
Niklaus Labhardt (Uni Basel, DKF*)
Introducing the Department Clinical Research
Elisabetta Traggiai (Novartis)
T-Cell Engagers, backtranslation from clinic to drug design
Falko Schlottig (FHNW*)
Introducing the FHNW School of Life Sciences (FHNW)
Abdullah Kahraman (FHNW*)
Cancer-specific transcripts as novel biomarker for precision medicine
Adrian Britschgi (Roche/pRED*)
Introducing Roche/pRED
Adrian Britschgi (pRED/Roche*)
Targeting cancer cell intrinsic pathways to tackle colorectal cancer
14.50: Coffee
15.20 – 17.00: Session IV: From Neuroscience to Neurology
Chair: Alex Schier / Michaela Kneissel
Alex Schier (Uni Basel, Biozentrum)
Introducing the Biozentrum Basel
Cristina Granziera (Uni Basel DBE, USB*)
Neurology 4.0 & beyond
Peter Scheiffele (Uni Basel, Biozentrum)
Tuning neuronal wiring and function through selective mRNA translation
Dirk Schübeler (FMI*)
Introducing the Friedrich Miescher Institute for Biomedical Research
Silvia Arber (FMI, Biozentrum*)
Circuits for Movement
Andreas Papassotiropoulos/ Dominique De Quervain (Uni Basel DBM, UPK*)
Genome-guided discovery of memory-enhancing drugs
Michaela Kneissel (Novartis)
Introducing Novartis
Derya Shimshek (Novartis)
Modulation of neuroinflammation as therapeutic approach in chronic neurodegenerative diseases
Alexandre Datta (UKBB*)
Introducing the University Children’s Hospital Basel (UKBB)
17.00: Apéro / Networking
Scientific Board des Basel Biomed Symposium
- Prof. Dr. Primo Schär, Vice President for Research, 51吃瓜
- Prof. Dr. Alex Schier, Head Department Biozentrum, 51吃瓜
- Prof. Dr. Ivan Martin, Head Department of Biomedicine, 51吃瓜
- Prof. Dr. Jürg Steiger, Chief Medical Director, University Hospital
- Prof. Dr. Daniel Müller, Department BSSE, ETH Zürich
- Dr. Annette Luther, Hoffmann-La Roche
- Dr. Michaela Kneissel, Global Head Diseases of Aging and Regenerative medicine, Novartis
* DBM, Department of Biomedicine; FMI Friedrich Miescher Institute for Biomedical Research; D-BSSE, Department of Biosystems Science and Engineering (ETHZ); USB, University Hospital Basel; IOB, Institute of Molecular and Clinical Ophthalmology Basel; IHB, Institute of Human Biology Basel; BRCCH, Basel Research Center for Child Health; DBE; Department of Biomedical Engineering; Swiss TPH, Swiss Tropical and Public Health Institute; DPS, Department of Pharmaceutical Sciences; DKF, Department Clinical Research; FHNW, Fachhochschule Nordwestschweiz; UPK, Universitäre Psychiatrische Kliniken Basel; UKBB, Universitäts-Kinderspital Beider Basel
